JP2002087964A5 - - Google Patents

Download PDF

Info

Publication number
JP2002087964A5
JP2002087964A5 JP2000263735A JP2000263735A JP2002087964A5 JP 2002087964 A5 JP2002087964 A5 JP 2002087964A5 JP 2000263735 A JP2000263735 A JP 2000263735A JP 2000263735 A JP2000263735 A JP 2000263735A JP 2002087964 A5 JP2002087964 A5 JP 2002087964A5
Authority
JP
Japan
Prior art keywords
composition
testosterone
isopropyl myristate
active pharmaceutical
pharmaceutical ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000263735A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002087964A (ja
JP5039252B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000263735A priority Critical patent/JP5039252B2/ja
Priority claimed from JP2000263735A external-priority patent/JP5039252B2/ja
Publication of JP2002087964A publication Critical patent/JP2002087964A/ja
Publication of JP2002087964A5 publication Critical patent/JP2002087964A5/ja
Application granted granted Critical
Publication of JP5039252B2 publication Critical patent/JP5039252B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000263735A 2000-08-31 2000-08-31 性機能低下を治療するための医薬組成物及び方法 Expired - Lifetime JP5039252B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000263735A JP5039252B2 (ja) 2000-08-31 2000-08-31 性機能低下を治療するための医薬組成物及び方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000263735A JP5039252B2 (ja) 2000-08-31 2000-08-31 性機能低下を治療するための医薬組成物及び方法

Publications (3)

Publication Number Publication Date
JP2002087964A JP2002087964A (ja) 2002-03-27
JP2002087964A5 true JP2002087964A5 (sv) 2007-10-11
JP5039252B2 JP5039252B2 (ja) 2012-10-03

Family

ID=18751240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000263735A Expired - Lifetime JP5039252B2 (ja) 2000-08-31 2000-08-31 性機能低下を治療するための医薬組成物及び方法

Country Status (1)

Country Link
JP (1) JP5039252B2 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029694B2 (en) * 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
JP2008538753A (ja) * 2005-04-12 2008-11-06 ユニメド ファーマスーティカルズ インク 骨の老化または骨粗しょう症の治療または予防方法
CN101287470B (zh) 2005-10-12 2012-10-17 优尼麦德药物股份有限公司 改良的睾酮凝胶及使用方法
JP6457899B2 (ja) * 2015-07-22 2019-01-23 アズビル株式会社 標準信号発生器
JP7121999B2 (ja) * 2019-09-26 2022-08-19 学校法人九州文化学園 男性性腺機能低下症治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
ES2318233T3 (es) * 1997-11-10 2009-05-01 Strakan International Limited Sistemas mejoradores de la penetracion y reductores de la irritacion que comprenden testosterona.
TR200300776T2 (tr) * 2000-08-30 2005-10-21 Unimed Pharmaceuticals, Inc. Erkeklerde cinsel organ sertleşmemesinin tedavi edilmesi ve libidonun arttırılması için yöntem.

Similar Documents

Publication Publication Date Title
AU2003233653B2 (en) Compositions and method for transmucosal drug delivery and cryoprotection
JP2004524267A5 (sv)
AU725283B2 (en) Bioadhesive pharmaceutical composition for the controlled release of active principles
AU2010299607B2 (en) Formulations comprising triptan compounds
CO5160329A1 (es) Metodo para proveer absorcion incrementada de una amina far- maceuticamente aceptable en la sangre de un humano y composi cion que comprende una amina farmaceuticamente un farmaco antiinflamatorio no esteroidal
US20030072814A1 (en) Topical pharmaceutical composition for the treatment of warts
US20050020552A1 (en) Pharmaceutical composition and method for transdermal drug delivery
ES2175799T3 (es) Forma de dosificacion para administracion en aerosol.
JP2004534839A5 (sv)
AU2681300A (en) Solid oral dosage form containing an enhancer
JP2003512393A5 (sv)
RU2004124720A (ru) Плоский или пластинчатый лекарственный препарат с исправленным вкусом
JP2012513955A5 (sv)
JP2013515002A5 (sv)
RU2004106779A (ru) Способ профилактики и/или лечения дисфункции и/или нарушения структуры ногтей, пластырь для его осуществления и его применение
JP4597273B2 (ja) 経口組成物
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
JP2009518374A (ja) 活性薬剤、特にジクロフェナクの経皮投与
WO2009113051A3 (en) Oral modified-release formulations containing thiazepines
MXPA05011724A (es) Productos dulces para liberar agentes farmaceuticamente activos a la garganta.
WO2004000268A1 (en) Topical administration of pharmacologically active bases in the treatment of warts
JP2002087964A5 (sv)
ES2197077T3 (es) Dispositivo transdermico que comprende farmacos anti-inflamatorios no esteroides incorporados en una matriz de un polimero acrilico adhesivo.
JP2006516141A5 (sv)
JP2002537232A5 (sv)